Performance Characterization and Validation of Saliva as an Alternative Specimen Source for Detecting Hereditary Breast Cancer Mutations by Next Generation Sequencing
Identification of pathogenic germline mutations by next generation sequencing is a widely accepted tool for predicting the risk of hereditary cancer development. Blood is the most common source of DNA for such tests. However, blood as a sample type has many drawbacks, including the invasive collecti...
Saved in:
| Main Authors: | Varsha Meghnani, Nadeem Mohammed, Christopher Giauque, Rahul Nahire, Thomas David |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2016/2059041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01) -
Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing
by: Najim Ameziane, et al.
Published: (2012-01-01) -
Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing.
by: Robert King, et al.
Published: (2015-01-01) -
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
by: Holly LaDuca, et al.
Published: (2017-01-01) -
Whole exome sequencing: the search for mutations associated with hereditary breast cancer in ethnic groups of Siberia
by: P. A. Gervas, et al.
Published: (2024-11-01)